Dr Cohen on Treatment Considerations for Relapsed/Refractory MCL

Jonathon B. Cohen, MD, MS, discusses treatment considerations for mantle cell lymphoma and the role of pirtobrutinib in the management of this disease.

Related Keywords

Jonathonb Cohen , ,Safety Monitoring Committee ,Emory University School Of Medicine ,Lymphoma Program ,Winship Cancer Institute ,Department Of Hematology ,Medical Oncology ,Emory University School ,Winship Cancer Institute Of Emory University ,Mantle Cell Lymphoma ,Cmcl ,Onclive Tv ,